article thumbnail

The hospital pharmacy landscape in 2024

Hospital Pharmacy Europe

Tiene Bauters, PharmD PhD, Pharmacy Department , Ghent University Hospital in Belgium, offers her take on what’s hot on the horizon for hospital pharmacy in 2024. In conclusion, we can see that pharmacy in 2024 will be filled with opportunities that we should embrace to help us continue to shape the future of our profession.

Hospitals 111
article thumbnail

Wegovy backorder: Why it happens and what to do about it

The Checkup by Singlecare

In January 2024, Novo Nordisk announced that it was boosting the supply of Wegovy and would more than double the amount of the lower dose strengths of Wegovy into the U.S. Others have just waited or turned to a compounded version of the drug,” Dr. Jordan says. In March 2022, the drug landed on the FDA’s list of drugs in short supply.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Does Medicare cover Ozempic?

The Checkup by Singlecare

Unfortunately, a law from 2003 prohibits Medicare Part D from covering weight loss drugs, which means it won’t cover Ozempic prescribed solely for weight loss , an off-label use. For the year 2024, Medicare Part D deductibles will be no more than $545 , and copayments can vary. But out-of-pocket maximums are much higher.

article thumbnail

Getting Quality Supplements

The Thyroid Pharmacist

This is because I had learned about various adulterants found in supplements, how some supplement manufacturers don’t actually put the products that are on the label in the bottle, or that the dosages listed on the label may be completely different from what’s in the products. We have 95 expiring in March 2024.)

article thumbnail

T2D market growth driven by novel GLP-1RAs and once-weekly basal insulin therapies

Pharmaceutical Technology

billion in 2029, with drug sales almost doubling at a compound annual growth rate (CAGR) of 11.5%. Specifically, across all the major classes there are significant developments, label updates, and biosimilar launches that are driving their growth. billion in sales in 2019, increasing to $136.2

article thumbnail

The Pandemic Treaty and the opportunity to end ‘vaccine apartheid’

pharmaphorum

The negotiations over the treaty are being hosted through the World Health Organization (WHO), with plans to officially adopt a binding agreement sealed by the United Nations health agency’s member countries in May 2024. The UN Special Rapporteur on contemporary forms of racism, E.

article thumbnail

CMS Finalizes Guidance on Medicare Part D Manufacturer Discount Program

The FDA Law Blog

As part of this change, the Coverage Gap Discount Program (CGDP), a program that has existed since 2011, will sunset on December 31, 2024, and be replaced by the Medicare Part D Manufacturer Discount Program (the “Discount Program”). Manufacturers must sign the agreement by March 1, 2024, to participate in the 2025 plan year.

Labelling 105